M
Mastitia is developing a microbiome-friendly therapeutic solution to treat mastitis in breastfeeding mothers. This approach aims to reduce the reliance on antibiotics, which can negatively impact infant health via breast milk transfer. The company's innovation supports continued breastfeeding while addressing global health concerns related to antimicrobial resistance.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Mastitia is developing a microbiome-friendly therapeutic solution to treat mastitis in breastfeeding mothers. This approach aims to reduce the reliance on antibiotics, which can negatively impact infant health via breast milk transfer. The company's innovation supports continued breastfeeding while addressing global health concerns related to antimicrobial resistance.